Department of Urology, School of Medicine, Stanford University, Stanford, California.
Department of Maternal-Infant and Urological Sciences, "Sapienza" Rome University, Policlinico Umberto I Hospital, Rome, Italy.
Fertil Steril. 2020 Mar;113(3):469-477. doi: 10.1016/j.fertnstert.2020.01.002. Epub 2020 Feb 20.
Male reproduction is a complex process, and numerous medical conditions have the potential to alter spermatogenesis. In addition, male factor infertility may be a biomarker for future health. In the present review, we discuss the current literature regarding the association between systemic diseases and fertility, which may impact clinical outcomes or semen parameters. A number of conditions that have systemic consequences were identified, including genetic (e.g., cystic fibrosis, DNA mismatch repair alterations), obesity, psychological stress, exogenous testosterone, and a variety of common medications. As such, the infertility evaluation may offer an opportunity for health counseling beyond the discussion of reproductive goals. Moreover, male infertility has been suggested as a marker of future health, given that poor semen parameters and a diagnosis of male infertility are associated with an increased risk of hypogonadism, cardiometabolic disease, cancer, and even mortality. Therefore, male fertility requires multidisciplinary expertise for evaluation, treatment, and counseling.
男性生殖是一个复杂的过程,许多医学疾病都有可能改变精子发生。此外,男性因素不孕可能是未来健康的一个生物标志物。在本综述中,我们讨论了与生育能力相关的系统性疾病的现有文献,这些疾病可能会影响临床结果或精液参数。确定了一些具有全身影响的疾病,包括遗传疾病(例如囊性纤维化、DNA 错配修复改变)、肥胖、心理压力、外源性睾酮和各种常见药物。因此,除了讨论生殖目标外,不孕评估还可能提供健康咨询的机会。此外,由于精液参数差和男性不育症的诊断与性腺功能减退症、心血管代谢疾病、癌症甚至死亡率增加有关,因此男性不育症被认为是未来健康的一个标志物。因此,男性生育能力需要多学科专业知识进行评估、治疗和咨询。